Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts
接受整合酶链转移抑制剂、替诺福韦艾拉酚胺或两者联合治疗的人群中，BMI 变化与高血压和血脂异常风险之间的关联，与接受其他当代抗逆转录病毒治疗方案的人群进行比较：一项来自 RESPOND 联盟队列的多中心前瞻性观察研究
期刊:Lancet HIV
影响因子:13
doi:10.1016/S2352-3018(23)00328-4
Byonanebye, Dathan M; Polizzotto, Mark N; Maltez, Fernando; Rauch, Andri; Grabmeier-Pfistershammer, Katharina; Wit, Ferdinand; De Wit, Stéphane; Castagna, Antonella; d'Arminio Monforte, Antonella; Mussini, Cristina; Wasmuth, Jan-Christian; Fontas, Eric; Abela, Irene; Sarcletti, Mario; Bansi-Matharu, Loveleen; Jaschinski, Nadine; Peters, Lars; Hosein, Sean R; Vannappagari, Vani; Cohen, Cal; Bissio, Emiliano; Mocroft, Amanda; Law, Matthew; Ryom, Lene; Petoumenos, Kathy
